Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance

Epidemiological and clinical analyses of cervical cancer using data from the population-based Osaka cancer registry

(2019) Asami Yagi et al.   CANCER RESEARCH

A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer

(2019) Beatrice Stubendorff et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

(2019) Wui-Jin Koh et al.   Journal of the National Comprehensive Cancer Network

Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype

(2019) Ann-Christin Frank et al.   Nature Communications

BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy

(2018) Christoph Oing et al.   CANCER LETTERS

Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries

(2018) Hongmei Zeng et al.   Lancet Global Health

Plasma m SEPT9 : A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma

(2018) Abderrahim Oussalah et al.   EBioMedicine

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort

(2018) Robert W. van Leeuwen et al.   INTERNATIONAL JOURNAL OF CANCER

Screening for Cervical Cancer

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions

(2018) Marjolein van Zummeren et al.   MODERN PATHOLOGY

Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer

(2018) Maria Arechederra et al.   Nature Communications

Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53- Deficient Prostate Cancer to Radiation

(2017) Anne L. van de Ven et al.   MOLECULAR CANCER THERAPEUTICS

Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies

(2017) Géraldine Genard et al.   Frontiers in Immunology

Non-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cells

(2016) Lee M. Butcher et al.   Nature Communications

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas

(2016) Alexander Semaan et al.   Clinical Epigenetics

Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL)

(2015) Takashi Sasayama et al.   BRAIN PATHOLOGY

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

(2015) Claudia Allemani et al.   LANCET

Comparison of Genetic and Epigenetic Alterations of Primary Tumors and Matched Plasma Samples in Patients with Colorectal Cancer

(2015) Elisa Danese et al.   PLoS One

On the presence and role of human gene-body DNA methylation

(2015) Daudi Jjingo et al.   Oncotarget

Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer

(2014) Xiaojing Yang et al.   CANCER CELL

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Comprehensive analysis of DNA methylation data with RnBeads

(2014) Yassen Assenov et al.   NATURE METHODS

High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma

(2014) Laura Stanbery et al.   Translational Oncology

Macrophage Regulation of Tumor Responses to Anticancer Therapies

(2013) Michele De Palma et al.   CANCER CELL

HMGB1 in Cancer: Good, Bad, or Both?

(2013) R. Kang et al.   CLINICAL CANCER RESEARCH

Human papillomavirus and cervical cancer

(2013) Emma J Crosbie et al.   LANCET

Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer

(2013) Brandon M Barney et al.   Radiation Oncology

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

(2011) Jorja D Warren et al.   BMC Medicine

Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse

(2010) Hung-Cheng Lai et al.   CANCER

Blockade of Tumor Necrosis Factor   Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy

(2010) Y. Meng et al.   CANCER RESEARCH

Replication timing-related and gene body-specific methylation of active human genes

(2010) Dvir Aran et al.   HUMAN MOLECULAR GENETICS

Modern Radiotherapy and Cervical Cancer

(2010) Melanie E.B. Powell   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Targeted Knockdown of SEPT9_v1 Inhibits Tumor Growth and Angiogenesis of Human Prostate Cancer Cells Concomitant with Disruption of Hypoxia-Inducible Factor-1 Pathway

(2010) Sharon Amir et al.   MOLECULAR CANCER RESEARCH

Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells

(2009) Madeleine P Ball et al.   NATURE BIOTECHNOLOGY

HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase II 

(2009) M. Stros et al.   NUCLEIC ACIDS RESEARCH